![]()
|
Report Date : |
13.01.2012 |
IDENTIFICATION DETAILS
|
Correct Name : |
SX BIOTECH CO., LTD |
|
|
|
|
Registered Office : |
MEIC Building, Narnyi Zam Street 63, 232, Ulaanbaatar 210628 |
|
|
|
|
Country : |
Mongolia |
|
|
|
|
Date of Incorporation : |
22.04.2008 |
|
|
|
|
Com. Reg. No.: |
9011150009 |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
Trading as importers, wholesalers and retailers of
laboratory equipment, instruments, chemicals, diagnostics and reagents. |
|
|
|
|
No. of Employees : |
7 |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Maximum Credit Limit : |
TUGRIK 10,000,000 |
|
|
|
|
Status : |
Small company |
|
|
|
|
Payment Behaviour : |
No complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com while quoting report
number, name and date.
ECGC Country Risk Classification List – September 30, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
Mongolia |
C1 |
C1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
SX Biotech Co.,
Ltd (Correct)
SX Biotech Office (Requested)
Building : MEIC Building
Street : Narnyi Zam Street 63
P.O.Box No. :
232
Town : Ulaanbaatar 210628
Country : Mongolia
Telephone : (976 50) 060 677 / (976 99) 040 584
(Erdene Chimeddorj) / (976 88) 132 385
Fax : (976 11) 323 877
E-Mail : erdene@sxbiotech.mn /
ayush@sxbiotech.mn
Shortform Name: SXB Co., Ltd
Name Position
1. Erdene Chimeddorj Executive Director
2. Ayush Erdene Sales Manager
3. Ninjbadam Enkhbaatar Sales Manger
Total Employees : 7
No complaints have been heard regarding payments from
local suppliers or banks.
We consider it is acceptable to deal with subject for
SMALL amounts,
although it is normal accepted practice for
international suppliers to deal on secured terms with Mongolian importers.
Opinion on maximum credit : TUGRIK 10,000,000
Trade risk assessment: Normal
NAME : TRADE AND
DEVELOPMENT BANK OF MONGOLIA
Branch : Zanabazar Branch, Chingeltei
District, Trade Street 7
Town : Ulaanbaatar
Telephone :
(976 11) 312 356 / 328 531 / 329 413
Fax : (976 11) 311 025
Private companies in Mongolia are not required to
publish or disclose balance sheets. However, the subject interviewed offered the
following information :
Sales Turnover
: TUGRIK 350,000,000 - 2010 - exact
: TUGRIK 490,000,000 - 2011 - exact
: TUGRIK 700,000,000 - 2012 - projected
Net Profit :
TUGRIK 50,000,000 - 2010 - exact
: TUGRIK
70,000,000 - 2011 - exact
Total value of current contracts : US DLRS 127,000
Financial year ends 31 December.
Date Started :
22 April 2008
C.R. No. :
9011150009
Tax No. :
5221293
Authorised Capital :
TUGRIK 4,000,000
Paid-Up Capital :
TUGRIK 4,000,000
Limited Liability Company with the following
shareholders:
Percentage
1. Erdene Chimeddorj 50%
(Mongolian national)
2. Zanabazar Enkhbaatar 50%
(Mongolian
national)
The Company is involved in the following activities :
Trading as importers, wholesalers and retailers of
laboratory equipment, instruments, chemicals, diagnostics and reagents.
NACE Code: 4675
Imports from USA, South Korea, Japan, Germany,
Finland, Belgium and China.
Subject does not export, all sales are domestic.
Subject’s suppliers include:
1. Cole Parmer International
USA
Telephone : (1 65) 9690 8208
E-Mail :
fning@coleparmer.com
Contact
person: Francis Ning - Asia Business Manager
2. Carl Roth GmbH
Schoemperlenstr. 1-5,
Karlsruhe
76185
Telephone : (49) 721 5606
Fax :
(49) 721 5606
E-Mail :
info@carlroth.de
Contact
Person: Wolfgang Treffinger - Export Mangaer
3. Intron Biotechnology, INC
South Korea
Telephone : (82 2) 449 2381
E-Mail : besieger@intronbio.com
Contact
Person: Lumy Kwon - Export Manager
The Company has the following facilities :
200 sq. m. rented premises comprising administrative
offices and storage facilities located at the heading address.
Until 2011 subject was located at :
Nisora Tower 604, Tokyo Street 14A
Ulaanbaatar
MEIC Building
Narnyi Zam Street 63
P.O.Box No.: 232
Ulaanbaatar 210628
You enquired on: SX Biotech Office. Please note that
the correct name is as per heading.
Interviewed: Erdene Chimeddorj (Executive Director).
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.51.83 |
|
|
1 |
Rs.79.42 |
|
Euro |
1 |
Rs.65.90 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment record
(10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.